SLC3A2 and breast cancer: Meanwhile, we demonstrated that only in BC patients with low SLC3A2 expression, the higher expression of CTL was positively correlated with patients' OS (Fig. 2C), suggesting that SLC3A2 might exert biological effects by affecting CTL infiltration in BC patients.